Fortress Biotech (FBIO) Jumps To Multi-Year Highs: Time To Get In?

Fortress Biotech was in the news on Tuesday after the company made a major announcement with regards to its operations. The company, which had been established by Fortress Biotech (NASDAQ: FBIO), announced on Tuesday that it formed a new scientific advisory board at the company.

The board in question is going to be independent and will be made up of five experts across diverse fields. The experts could be from the fields of lung cancer, skin cancers, and immunotherapy. The news about the establishment of this advisory proved to be a major boost for the Checkpoint stock as well and it soared by as high as 26% as investors piled on to it.

The board is going to work in conjunction with the company’s management and help Checkpoint in expanding its portfolio of products meant for treating solid tumors. It is easy to see why the news was welcomed so enthusiastically by investors. However, it remains to be seen if the stock can continue to ride the momentum and record further gains.

Michael Rowels

Weekend Contributor.Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.